← Back to Search

LAA Exclusion Device

AtriClip for Left Atrial Appendage Absent

N/A
Waitlist Available
Led By Elias Zias, MD
Research Sponsored by AtriCure, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months or greater post-procedure
Awards & highlights

Study Summary

This trial will look at the long-term effects of two devices used to close off the left atrial appendage of the heart. The study is non-randomized and unblinded, meaning that doctors will know which device each patient has, and patients will not be randomly assigned to a group.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months or greater post-procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months or greater post-procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Performance Endpoint
Primary Safety Endpoint
Secondary outcome measures
Device and Procedure long-term Safety
Long-term thromboembolic events
Performance

Trial Design

1Treatment groups
Experimental Treatment
Group I: AtriClip groupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

AtriCure, Inc.Lead Sponsor
42 Previous Clinical Trials
17,395 Total Patients Enrolled
Elias Zias, MDPrincipal InvestigatorNYU Langone Health

Media Library

AtriClip (LAA Exclusion Device) Clinical Trial Eligibility Overview. Trial Name: NCT05101993 — N/A
Left Atrial Appendage Absent Research Study Groups: AtriClip group
Left Atrial Appendage Absent Clinical Trial 2023: AtriClip Highlights & Side Effects. Trial Name: NCT05101993 — N/A
AtriClip (LAA Exclusion Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05101993 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~48 spots leftby May 2025